CRP and prostate carcinoma: In summary, we found, for the first time using a two-sample MR approach with an adequate statistical power (including 79,148 cases and 61,106 controls), that genetically predicted circulating CRP levels were not associated with prostate cancer risk, suggesting that CRP is unlikely to be a causal factor in the development of prostate cancer.